Technology
New On Robinhood
Health
NextCure
$14.569876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$14.56
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.06 (-0.41%) Today
$0.00 (0.00%) After Hours
Why Robinhood?
You can buy or sell NextCure and other stocks, options, ETFs, and crypto commission-free!
About
NextCure, Inc. Common Stock, also called NextCure, is a clinical-stage biopharmaceutical company, which engages in discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases. Read More Its novel FIND-IO discovery technology identifies targets based on immunomodulatory function and on which the company is building a proprietary pipeline of immunomedicines. The company was founded by Michael S. Richman and Lieping Chen in September 2015 and is headquartered in Beltsville, MD.
Employees
44
Headquarters
Beltsville, Maryland
Founded
2015
Market Cap
332.09M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
136.81K
High Today
$15.26
Low Today
$13.86
Open Price
$14.53
Volume
37.87K
52 Week High
$22.75
52 Week Low
$13.86
Collections
Technology
New On Robinhood
Health
Biotechnology
Medical
Biopharmaceutical
Cancer Prevention
Pharmaceutical
Price Paid on Robinhood
15% Lower
Right Now
52 Week Low
$13.86
Average Price Paid
$17.16
52 Week High
$22.75
Earnings
-$5.35
-$4.76
-$4.16
-$3.57
Q1 2019
Estimated
—
Actual
-$4.46 per share